Legal status · United Kingdom
Is Low-dose lithium legal in the United Kingdom?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Low-dose lithium can be sold in the United Kingdom as a supplement or cosmetic ingredient, classified as "Sold as a supplement". That is not drug approval: MHRA has not evaluated any health claim, and injectable or "research use only" versions fall outside supplement rules, so that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile.
Low-dose lithium in the United Kingdom at a glance
| Classification | Sold as a supplement |
|---|---|
| Note | Prescription lithium salts are licensed for bipolar disorder; low-dose orotate products sold as supplements carry no licensed indication. |
| MHRA approval status | Not a MHRA drug approval; sold as a supplement or cosmetic |
| Human studies cited | 4 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Low-dose lithium profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
Low-dose lithium can be sold in the United Kingdom as a supplement, food or cosmetic ingredient under the classification above, without drug approval.
- 02
Supplement status means MHRA has not evaluated any health claim; manufacturers are responsible for safety and labeling, and quality varies by product.
- 03
Injectable or "research use only" versions are not supplements. That label does not make human use lawful, and injectables fall under medicines rules.
What Low-dose lithium is
The drinking water literature that gets quoted as evidence is not a trial: 15 ecological studies pooled to a regression coefficient of -0.27 for suicide mortality, and the meta-analysis authors label their own result as subject to the ecological fallacy. The randomised trials that exist used lithium carbonate at 150 to 600 mg targeting a blood level, which is a different intervention from the milligram doses of lithium orotate sold in shops.
Low-dose lithium is where an entire consumer category has been built on top of a study design that cannot support it, and where the actual randomised evidence is for a different dose of a different salt. The popular case rests on ecological studies.
Mechanism: Lithium inhibits glycogen synthase kinase 3 beta, which is upstream of tau phosphorylation and of amyloid precursor protein processing, and it inhibits inositol monophosphatase, depleting the inositol pool that supports phosphatidylinositol signalling. Both mechanisms are dose-dependent, and the doses at which they have been demonstrated in human brain are the prescription ones, monitored by serum level.
Regulatory history: Lithium carbonate and lithium citrate are FDA-approved prescription medicines for bipolar disorder, with mandatory serum level monitoring. Lithium orotate is sold as a dietary supplement and has no approved indication and no monitoring requirement.
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Low-dose lithium at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Low-dose lithium in other countries
Frequently asked questions
Is Low-dose lithium legal in the United Kingdom?
Low-dose lithium can be sold in the United Kingdom as a supplement or cosmetic ingredient, classified as "Sold as a supplement". That is not drug approval: MHRA has not evaluated any health claim, and injectable or "research use only" versions fall outside supplement rules, so that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile. Note: Prescription lithium salts are licensed for bipolar disorder; low-dose orotate products sold as supplements carry no licensed indication.
Can I buy Low-dose lithium in the United Kingdom?
Yes, in supplement or cosmetic form. In the United Kingdom Low-dose lithium is classified as "Sold as a supplement", so oral, topical or cosmetic products can be sold under supplement rules. Injectable versions and products labeled "research use only" are not supplements and are not approved for human use. Note: Prescription lithium salts are licensed for bipolar disorder; low-dose orotate products sold as supplements carry no licensed indication.
Is Low-dose lithium MHRA approved?
No. In the United Kingdom Low-dose lithium is classified as "Sold as a supplement", which is not a MHRA marketing approval. For comparison, the US FDA status is: Lithium carbonate and lithium citrate are FDA-approved prescription medicines for bipolar disorder, with mandatory serum level monitoring. Lithium orotate is sold as a dietary supplement and has no approved indication and no monitoring requirement.. On the evidence, 4 human studies are cited on its profile.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Low-dose lithium live on its compound profile.
Low-dose lithium profileThis page is general information about the regulatory status of Low-dose lithium in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.